Activity of a Nitroxylated Analog of Daunorubicin, Ruboxyl, in B-Lymphoproliferative Disorders

Publisher： Karger

E-ISSN： 1421-9662|105|2|77-82

ISSN： 0001-5792

Source： Acta Haematologica, Vol.105, Iss.2, 2001-06, pp. : 77-82

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lymphoproliferative Disorders of the Lung

By  

Respiration, Vol. 94, Iss. 2, 2017-06 ,pp. : 157-175

Karger

Access to resources Recommend Favorite

Angiogenesis in Lymphoproliferative Disorders

By  

Acta Haematologica, Vol. 106, Iss. 4, 2002-01 ,pp. : 184-189

Karger

Access to resources Recommend Favorite

Clinicopathological characteristics and rituximab addition to cytotoxic therapies in patients with rheumatoid arthritis and methotrexate‐associated large B lymphoproliferative disorders

By  

HISTOPATHOLOGY, Vol. 67, Iss. 1, 2015-07 ,pp. : 70-80

John Wiley & Sons Inc

Access to resources Recommend Favorite

Lymphoproliferation in hepatitis C

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 4, 2015-04 ,pp. : 742-747

John Wiley & Sons Inc

Access to resources Recommend Favorite

Post‐transplant lymphoproliferative disorders with naso‐ and oropharyngeal manifestation

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 11, 2015-11 ,pp. : 1299-1307

John Wiley & Sons Inc

Access to resources Recommend Favorite